Hyala Vanyne da Cunha Araújo Santana

Hyala Vanyne da Cunha Araújo Santana

Auto-generated profile, based on publicly available information

Hyala Vanyne da Cunha Araújo Santana

Universidade Maurício de Nassau

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2023 in Scire Salutis
Verified
Journal Article
Open access
PDF file
HSHyala Vanyne da Cunha Araújo Santana
Hyala Vanyne da Cunha Araújo Santana
VSVictoria Aragão da Silva
Victoria Aragão da Silva
LSLuiz Silva
Luiz Silva
RSRomário Vinícius de Souza Santos
Romário Vinícius de Souza Santos
CSCarlos Adriano Santos Souza
Carlos Adriano Santos Souza
MSMarilia Trindade de Santana Souza
Marilia Trindade de Santana Souza
The anxiety is a common fight or flight response from the body, however, it can be intense and bring harm to human beings. The anxiety disorders affect several people and present symptoms that impair the personal and professional development, and can be treated with psychotherapy and, in more advanced cases, resorts to pharmacological treatment. The purpose of this research is to conduct a review of scientific evidence that exists in the pharmacological treatment of anxiety disorders. The Metodology carried out was a review in wich the following descriptors were used: Anxiety, pharmacological treatment; na base Pubmed. The data collections was performed by two independent reviewers. The results obtained in relation of the study were found the disorders Generalized Anxiety Disorder (GAD), Social Anxiety Disorder(SAD), Panic Disorder (PD), Post-Traumatic Stress Disorder (PTSD), Anxiety Disorder (AD), Obsessive-Compulsive Disorder (OCD), Depressive Disorder (DD), Acrophobia, Mixed Axiety (MA), Preoperative Axiety (PA), Phobia of Snakes (FC), ASD, AGD and or Separation in children or adolescents, Major Depressive Disorder (MDD) with high levels of anxiety, Humor e Anxiety Disorder; and the classes for treatment Serotonin and Norepinephrine Reuptake Inhibitors (SNRI), Selective Serotonin Reuptake Inhibitors (SSRI), Benzodiazepines (BDZ), Anticonvulsants, Antibiotic, Atypical and Tricyclic Antidepressant, Beta-blockers, Neuroleptics, Melatonin Receptor, Monoamine oxidase Inhibitors (MAOI). It is concluded that the drug classes will be analyzed with the type and degree of the disorder and the duration of the treatments, each class has its specificity.